These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 24886114)

  • 1. Whole lung lavage combined with Granulocyte-macrophage colony stimulating factor inhalation for an adult case of refractory pulmonary alveolar proteinosis.
    Yu Hy; Sun Xf; Wang Yx; Xu Zj; Huang H
    BMC Pulm Med; 2014 May; 14():87. PubMed ID: 24886114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A combination therapy of whole lung lavage and GM-CSF inhalation in pulmonary alveolar proteinosis.
    Yamamoto H; Yamaguchi E; Agata H; Kandatsu N; Komatsu T; Kawai S; Baba K; Awaya T; Nishikomori R; Tsurusawa M; Nakata K
    Pediatr Pulmonol; 2008 Aug; 43(8):828-30. PubMed ID: 18618617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined-modality therapy for pulmonary alveolar proteinosis in a remote setting: a case report.
    Boyce DSK; Lee JW; Shah P; Freeman JH; Aboudara MC; Hostler DC
    BMC Pulm Med; 2019 Mar; 19(1):61. PubMed ID: 30866900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granulocyte-Macrophage Colony-Stimulating Factor Inhalation Therapy for Severe Pulmonary Alveolar Proteinosis.
    Zhen G; Li D; Jiang J; Weng Y
    Am J Ther; 2020 Mar; 28(2):e171-e178. PubMed ID: 31513019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential Granulocyte-Macrophage Colony-Stimulating Factor Inhalation after Whole-Lung Lavage for Pulmonary Alveolar Proteinosis. A Report of Five Intractable Cases.
    Ohkouchi S; Akasaka K; Ichiwata T; Hisata S; Iijima H; Takada T; Tsukada H; Nakayama H; Machiya JI; Irokawa T; Ogawa H; Shibata Y; Ichinose M; Ebina M; Nukiwa T; Kurosawa H; Nakata K; Tazawa R
    Ann Am Thorac Soc; 2017 Aug; 14(8):1298-1304. PubMed ID: 28421817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granulocyte macrophage colony stimulating factor therapy for pulmonary alveolar proteinosis.
    Shende RP; Sampat BK; Prabhudesai P; Kulkarni S
    J Assoc Physicians India; 2013 Mar; 61(3):209-11. PubMed ID: 24475687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experience with treatment of pulmonary alveolar proteinosis from a tertiary care centre in north India.
    Khan A; Agarwal R; Aggarwal AN; Bal A; Sen I; Yaddanapuddi LN; Puri GD
    Indian J Chest Dis Allied Sci; 2012; 54(2):91-7. PubMed ID: 22973777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Patient with autoimmune alveolar proteinosis who did not respond to GM-CSF inhalation therapy and underwent repeated whole-lung lavage].
    Ueda Y; Matsuo K; Tsushima M; Mizuta M; Fujiwara K; Yonei T; Sato T
    Nihon Kokyuki Gakkai Zasshi; 2009 Sep; 47(9):833-8. PubMed ID: 19827590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole lung lavage and GM-CSF use for pulmonary alveolar proteinosis in an infant with lysinuric protein intolerance: a case report.
    Vojcek E; Krikovszky D; Lódi C; Kovács L; Schnur J; Szabó AJ
    Ital J Pediatr; 2024 Jun; 50(1):111. PubMed ID: 38831374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A plasmapheresis protocol for refractory pulmonary alveolar proteinosis.
    Garber B; Albores J; Wang T; Neville TH
    Lung; 2015 Apr; 193(2):209-11. PubMed ID: 25557091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary alveolar proteinosis during a 30-year observation. Diagnosis and treatment.
    Fijołek J; Wiatr E; Radzikowska E; Bestry I; Langfort R; Polubiec-Kownacka M; Prokopowicz J; Roszkowski-Śliż K
    Pneumonol Alergol Pol; 2014; 82(3):206-17. PubMed ID: 24793148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ten-year experience of whole lung lavage in pediatric Pulmonary Alveolar Proteinosis.
    Nickel K; Schütz K; Carlens J; Grewendorf S; Wetzke M; Keil O; Dennhardt N; Rigterink V; Köditz H; Sasse M; Happle C; Beck CE; Schwerk N
    Klin Padiatr; 2024 Feb; 236(2):64-72. PubMed ID: 38262422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmapheresis for treatment of pulmonary alveolar proteinosis.
    Luisetti M; Rodi G; Perotti C; Campo I; Mariani F; Pozzi E; Trapnell BC
    Eur Respir J; 2009 May; 33(5):1220-2. PubMed ID: 19407056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bilateral single sesion whole lung lavage under venous-venous ECMO in a case of severe pulmonary alveolar proteinosis: five years follow up].
    Wainstein EJ; Las Heras M; Sinner J; Kotowicz V; Precerutti J; San Román J; Svetliza G
    Rev Fac Cien Med Univ Nac Cordoba; 2019 Jun; 76(2):121-123. PubMed ID: 31216168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary alveolar proteinosis: time to shift?
    Papiris SA; Tsirigotis P; Kolilekas L; Papadaki G; Papaioannou AI; Triantafillidou C; Papaporfyriou A; Karakatsani A; Kagouridis K; Griese M; Manali ED
    Expert Rev Respir Med; 2015 Jun; 9(3):337-49. PubMed ID: 25864717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary alveolar proteinosis in adults: pathophysiology and clinical approach.
    Kumar A; Abdelmalak B; Inoue Y; Culver DA
    Lancet Respir Med; 2018 Jul; 6(7):554-565. PubMed ID: 29397349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to inhaled granulocyte-macrophage colony-stimulating factor in patient with mild-to-moderate autoimmune pulmonary alveolar proteinosis-24 months of follow-up.
    Oterino-Moreira I; Linares-Asensio MJ; Sanz-Márquez S; Pérez-Encinas M
    Clin Respir J; 2023 Oct; 17(10):1077-1081. PubMed ID: 37300395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An open-label trial of granulocyte macrophage colony stimulating factor therapy for moderate symptomatic pulmonary alveolar proteinosis.
    Venkateshiah SB; Yan TD; Bonfield TL; Thomassen MJ; Meziane M; Czich C; Kavuru MS
    Chest; 2006 Jul; 130(1):227-37. PubMed ID: 16840407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful Treatment of Autoimmune Pulmonary Alveolar Proteinosis in a Pediatric Patient.
    Trukalj M; Perica M; Ferenčić Ž; Erceg D; Navratil M; Redžepi G; Nogalo B
    Am J Case Rep; 2016 Sep; 17():641-5. PubMed ID: 27592713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhaled recombinant GM-CSF reduces the need for whole lung lavage and improves gas exchange in autoimmune pulmonary alveolar proteinosis patients.
    Campo I; Carey BC; Paracchini E; Kadija Z; De Silvestri A; Rodi G; De Amici M; Torre C; Zorzetto M; Griese M; Meloni F; Corsico AG; Trapnell BC; Mariani F
    Eur Respir J; 2024 Jan; 63(1):. PubMed ID: 37973175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.